Evaluation of the Effects of Training at Different Intensities in Coronary Artery Patients
NCT ID: NCT06474624
Last Updated: 2024-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
78 participants
INTERVENTIONAL
2023-05-26
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Despite research to date, the basis of the disease is still poorly understood, with chronic dysfunction of the autonomic nervous system being proposed as such a basis, as well as pathophysiological and pathogenic approaches. Hypertension has been implicated in the development of cardiovascular risk factors such as diabetes and dyslipidaemia and is directly linked to mortality caused by coronary artery disease.
Moderate Intensity Continuous Training (MICT) has been recognised as the gold standard for many years. However, for some time, different researchers have adopted the high-intensity interval training model (HIIT) as the most effective method in terms of objective adaptations of most cardiac rehabilitation programmes in patients with coronary artery disease (CAD) and congestive heart failure.
High-intensity interval training (HIIT) consists of cycles between warm-up and cool-down periods, high-intensity exercise intensity followed by an active recovery period. The duration and intensity of these cycles vary between studies and there is no consensus on which is the optimal cycle. In general, the high-intensity exercise phase is applied at 80-100% of VO2 max and the active recovery phase is used between 50-70% of VO2 max.
In Moderate Intensity Continuous Training the submaximal exercise intensity determined in accordance with the patient's functional capacity between the warm-up and cool-down periods is applied for a fixed period. The Moderate Intensity Continuous Training is planned to consist of 20-30 minute sessions between 50-70% of maximum oxygen consumption (VO2max).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Combined Upper and Lower Extremity Endurance Training in Patients With ICD
NCT04803968
Effects of Intermittent Exercise Training Programs in Patients With Myocardial Infarction
NCT04407624
Cardiac Rehabilitation in Heart Failure and Sarcopenia
NCT07245459
Clinical Relevance of Different Training Intensities in Chronic Heart Failure.
NCT05213546
The Health Impact of High Intensity Exercise Training With Intervals During Cardiac Rehabilitation
NCT02376244
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Moderate Intensity Continuous Training
* A total of 24 -30 (8-10 weeks) sessions of an exercise-based Cardio Rehabilitation program 3 days a week.
* Cycling for 20-30 minutes at 50-70% of Wmax between warm-up and cool-down periods.
Cardio Rehabilitation program
A total of 24 30 (8-10 weeks) sessions of an exercise-based Cardio Rehabilitation program 3 days a week.
Cycling for 20-30 minutes
Cycling for 20-30 minutes at 50-70% of Wmax between warm-up and cool-down periods.
High-intensity interval training
* A total of 24 -30 (8-10 weeks) sessions of an exercise-based Cardiac Rehabilitation program 3 days a week.
* Cycling a total of 4 cycles consisting of 4 minutes at 85-100% of Wmax followed by 3 minutes of active recovery periods at 50-70% of Wmax between warm-up and cool-down periods.
Cardio Rehabilitation program
A total of 24 30 (8-10 weeks) sessions of an exercise-based Cardio Rehabilitation program 3 days a week.
Cycling a total of 4 cycles
Cycling a total of 4 cycles consisting of 4 minutes at 85-100% of Wmax followed by 3 minutes of active recovery periods at 50-70% of Wmax between warm-up and cool-down periods.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardio Rehabilitation program
A total of 24 30 (8-10 weeks) sessions of an exercise-based Cardio Rehabilitation program 3 days a week.
Cycling for 20-30 minutes
Cycling for 20-30 minutes at 50-70% of Wmax between warm-up and cool-down periods.
Cycling a total of 4 cycles
Cycling a total of 4 cycles consisting of 4 minutes at 85-100% of Wmax followed by 3 minutes of active recovery periods at 50-70% of Wmax between warm-up and cool-down periods.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being with stable New York Heart Association functional class I or II coronary artery disease with angina pectoris or myocardial infarction,
* Having a left ventricular ejection fraction of 40% or above,
* Being clinically stable for more than 2 weeks in terms of symptoms and medical treatment.
Exclusion Criteria
* Being in Class III-IV according to the New York Heart Classification,
* Presence of significant left ventricular outflow obstruction,
* Ventricular arrhythmia,
* Significant valvular heart disease,
* Failure to comply with the rules of exercise testing and training,
* Significant orthopaedic or neurological comorbidity preventing full participation.
* Less than 80% participation in the treatment programme
* Metabolic, haematological or other inflammatory diseases
* Known psychiatric illness
* Active malignancy and/or those diagnosed with malignancy within the last 5 years
* Those who have used tobacco products in the last 5 years
* BMI \>35
* History of major orthopaedic surgery within the last 6 months.
30 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kutahya Health Sciences University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatima Yaman
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kutahya University of Health Sciences Evliya Çelebi Physical Medicine and Rehabilitation Clinic, Cardiopulmonary Rehabilitation Unit
Kütahya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-08/01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.